Azadeh Feizpour

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Impact of plasma pTau181 levels on clinician diagnostic confidence and management in memory and cognition clinics: A multi-site before-and-after study.

Impact of plasma pTau181 levels on clinician diagnostic confidence and management in memory and cognition clinics: A multi-site before-and-after study.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: February 25, 2026

Visual read performance of 18F-Florbetapir and 18F-NAV4694 Aβ PET compared against Centiloid reference standard in a paired cohort.

Visual read performance of 18F-Florbetapir and 18F-NAV4694 Aβ PET compared against Centiloid reference standard in a paired cohort.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: December 04, 2025

Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectories.

Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectories.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 28, 2025

When Does Alzheimer's Disease Start? Plasma Aβ42/40 Assays Show Steep Changes at Aβ-PET Centiloid 15, Mean Age of 66 Years.

When Does Alzheimer's Disease Start? Plasma Aβ42/40 Assays Show Steep Changes at Aβ-PET Centiloid 15, Mean Age of 66 Years.

Journal: Annals of neurology

Published: September 24, 2025

Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease.

Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease.

Journal: JAMA neurology

Published: September 15, 2025

AI-enhanced Centiloid quantification of amyloid PET images.

AI-enhanced Centiloid quantification of amyloid PET images.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: August 14, 2025

Harmonizing neuropsychological test data across prospective studies.

Harmonizing neuropsychological test data across prospective studies.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: August 13, 2025

Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scans.

Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scans.

Journal: The journal of prevention of Alzheimer's disease

Published: July 07, 2025

Multivariate models using NULISAseq and plasma p-tau217 for staging Alzheimer's disease.

Multivariate models using NULISAseq and plasma p-tau217 for staging Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: June 22, 2025

Digital detector PET/CT increases Centiloid measures of amyloid in Alzheimer's disease: A head-to-head comparison of cameras.

Digital detector PET/CT increases Centiloid measures of amyloid in Alzheimer's disease: A head-to-head comparison of cameras.

Journal: Journal of Alzheimer's disease : JAD

Published: January 27, 2025

Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex.

Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex.

Journal: Nature neuroscience

Published: August 22, 2024

Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathology.

Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathology.

Journal: medRxiv : the preprint server for health sciences

Published: July 01, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026